Orchard Therapeutics PLC Sponsored ADR EBITDA Margin 2019-2023 | ORTX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Orchard Therapeutics PLC Sponsored ADR (ORTX) over the last 10 years. The current EBITDA margin for Orchard Therapeutics PLC Sponsored ADR as of September 30, 2023 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2023-09-30 | $0.02B | $-0.11B | -500.00% |
| 2023-06-30 | $0.02B | $-0.11B | -500.00% |
| 2023-03-31 | $0.02B | $-0.11B | -633.33% |
| 2022-12-31 | $0.02B | $-0.13B | -543.48% |
| 2022-09-30 | $0.02B | $-0.13B | -812.50% |
| 2022-06-30 | $0.01B | $-0.14B | -1245.45% |
| 2020-09-30 | $0.00B | $-0.17B | -4200.00% |
| 2020-06-30 | $0.00B | $-0.18B | -4600.00% |
| 2019-09-30 | $0.00B | $-0.16B | -5200.00% |
